Johnson & Johnson today announced its results for 2008 reporting sales of $63.7bn, an increase of 4.3% on 2007. According to the New Jersey-based company, its strong year on year performance was buoyed by a 9.7% increase in international sales, as well as the popularity of skin care lines Neutrogena and Clean & Clear, and the recent acquisition of China’s leading moisturiser, Dabao.
“I am extremely proud of Johnson & Johnson’s accomplishments in 2008 and the way our people met our commitments,” said William C Weldon, chairman and ceo. “I am confident that we are well positioned for continued leadership and growth in health care.”
However, Johnson & Johnson’s sales figures for the fourth quarter of 2008, down 4.9% to $15.2bn, in addition to a disappointing 0.4% decline in domestic sales suggest that it may not remain immune to the worsening global economic situation.